Early Morning Technical Insight: Bristol-Myers Squibb Co., Eli Lilly & Co., Endo Health Solutions Inc., and Allergan Inc. PR Newswire LONDON, November 27, 2013 LONDON, November 27, 2013 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. On Tuesday, November 26, 2013, both the S&P 500 and the NASDAQ Composite finished the day higher at 1,802.75, up 0.01%, and 4,017.75, up 0.58%, respectively. The Dow Jones Industrial Average, on the other hand, closed flat at 16,072.80. Shares in healthcare-drug makers ended on a lower note, even as the broader market edged higher. The major movers in the sector included Bristol-Myers Squibb Company (NYSE: BMY), Eli Lilly & Company (NYSE: LLY), Endo Health Solutions Inc. (NASDAQ: ENDP), and Allergan Inc. (NYSE: AGN). All these companies are tracked by AAAResearchReports.com. Download free technical analysis and charting reports on BMY, LLY, ENDP, and AGN now at: http://www.aaaresearchreports.com/register/ On Tuesday, shares in Bristol-Myers Squibb Co. declined by 1.84%, even as the broader market posted gains. The company's shares closed the day at $51.88, after trading between $51.35 and $52.87. A total of 10.31 million shares were traded, which is above the daily average volume of 7.25 million. Despite Tuesday's decline, the company's shares have gained 6.38% in the last one month and 22.30% in the previous three months, outperforming the S&P 500, which has advanced 2.44% and 8.81% during the respective periods. Further, Bristol-Myers Squibb Co.'s stock is trading above its 50-day and 200-day moving averages of $49.60 and $44.10, respectively. Download free research on BMY today by registering at: http://www.AAAResearchReports.com/BMY112713.pdf Eli Lilly & Co.'s stock oscillated between $50.54 and $51.45 before ending Tuesday's session 1.56% lower at $50.54. A total of 5.52 million shares were traded, which is below the daily average volume of 6.09 million. Despite Tuesday's pullback, the company's shares have advanced 0.10% in the previous three trading sessions, compared to a gain of 0.38% in the S&P 500 during the same period. Moreover, Shares in Eli Lilly & Co.'s stock is trading above its 50-day moving average of $50.48. Sign up and have access to our free report on LLY at: http://www.AAAResearchReports.com/LLY112713.pdf Shares in Endo Health Solutions Inc. edged lower on Tuesday after hitting a new 52-week high of $67.23. The company's shares closed the day at $66.97, down 0.01% from the previous day's price of $66.98. A total of 1.06 million shares were traded, which is below the daily average volume of 2.63 million. Despite Tuesday's losses, the company's shares have surged 45.84% in the last one month and 70.28% in the previous three months, outperforming the S&P 500, which has gained 2.44% and 8.81% during the respective periods. Furthermore, Endo Health Solutions Inc.'s stock is trading above its 50-day and 200-day moving averages of $50.32 and $39.53, respectively. Sign up and read the complimentary report on ENDP at: http://www.AAAResearchReports.com/ENDP112713.pdf On Tuesday, Allergan Inc.'s stock ended the day at $97.39, which is 0.52% lower than the previous day's closing price of $97.90. The company's shares fluctuated between $97.37 and $98.03 during the trading session. A total of 1.60 million shares were traded, which is below the daily average volume of 2.06 million. Despite Tuesday's losses, the company's shares have gained 4.92% in the last one-month and 9.24% in the previous three months, outperforming the S&P 500, which has gained 2.44% and 8.81% during the respective periods. Additionally, Allergan Inc.'s stock is trading above its 50-day moving average of $91.87. The free report on AGN can be downloaded by signing up now at: http://www.AAAResearchReports.com/AGN112713.pdf ---- EDITOR NOTES: 1.This is not company news. We are an independent source and our views do not reflect the companies mentioned. 2.Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. 3.This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public. 4.If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com. 5.For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com. 6.Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration. COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be. NOT FINANCIAL ADVICE Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein. NO WARRANTY OR LIABILITY ASSUMED Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute. SOURCE AAA Research Reports Contact: Phone #: + 1 (646) 396-9126 Contact Name: Peter F. Jones Email ID: firstname.lastname@example.org
Early Morning Technical Insight: Bristol-Myers Squibb Co., Eli Lilly & Co., Endo Health Solutions Inc., and Allergan Inc.